New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Obagi Medical Products (OMPI)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
Topic Listing for Obagi Medical Products
Account
Accounting Stock-based Compensation
Accounts Receivable
Accrued Liabilities
Additional 2007 Full Information
Additional 2007 Information
Additional Information
Additional Insurance Obligations
Additional Purchase Order
Additional Transfers
Address
Adjustments Tenants Share
Administration
Advertising Costs
Aesthetic Skin Care
Affiliate
Agent
Agreement
Agreements Cellogique Corporation
Agreements Cno Chinese Obagi Corporation Vno Vietnamese
Agreements Governing Credit Facilities Impose Restrictions Business Limit
Albert Fitzgibbons
Albert Hummel
Already Delivered Proxy Card Voted Via Internet Respect
Amended Restated Certificate Incorporation Bylaws
Amended Restated Employment Agreement
Amendment Distributor Expense Provision
Amendment Lease
Amendment Payment Terms
Amendment Required Periodic Reviews
Amendments Future Subsidiaries
Amendments Waivers Remedies
Annual Bonus
Annual Forecast
Annual Meeting Stockholders
Annual Report Pursuant Securities Exchange Act 1934
Applicable Insolvency Laws
Applicable Law
Areas Future Growth
Assignment Binding Effect
Assumption 8212
At-will Employment
Attorneys Fees
Audit Committee
Audits
Austin Mcnamara
Authority
Avon
Balance Sheet Data
Base Salary
Basis Presentation
Because Currently Limited Commercial Manufacturing Capabilities Continue Dependent
Because Limited Research Development Capabilities Dependent Parties Perform
Beneficial Ownership Reporting Compliance
Bi-quarterly Review
Bi-quarterly Reviews Reports
Bimineral Complex Cost
Board Committees
Board Directors Executive Officers
Board Directors Issue Preferred Stock Without Stockholder Approval
Board Independence
Board Nominees 2007 Annual Meeting
Bonus Payment Amounts
Borrower
Borrowers
Borrowers8217 Financial Condition
Bradley Hoecker
Building Directory
Building Project
Business Strategy
Calculation Payment Additional Rent
Capital Leases
Cash Awards
Cash Equivalents
Cash Flow
Ccrs
Cellogique Corporation
Certain Relationships Related Transactions Director Independence
Certification Chief Executive Officer
Certification Chief Executive Officer Pursuant 302 Sarbanes-oxley Act
Certification Chief Financial Officer
Certification Chief Financial Officer Pursuant 302 Sarbanes-oxley Act
Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Certifications
Changes Internal Control Over Financial Reporting
Changes Interpretations Accounting Rules Regulations Such Expensing Stock
Channel
Chattel Paper
Clenziderm Md-acne
Clinical Development
Clinical Study Support
Code Ethics
Collateral
Comerica
Comerica Bank
Commercial Sale
Commitments Contractual Obligations
Common Areas
Common Stock
Communications Directors
Compared 2006
Compensation Committee
Compensation Committee Interlocks Insider Participation
Compensation Goals Philosophy
Competition
Compliance Law
Computer Records
Concentrations Credit Risk Significant Customers
Condemnation
Conditions Restrictions
Conference Call
Conference Call Information
Confidential Information
Consent Independent Registered Public Accounting Firm
Consent Jurisdiction
Construction Expansion Space
Construction Insurance
Construction Personnel
Controls Procedures
Copper Zinc Malonate
Copyright Collateral
Copyright Licenses
Copyrights
Corporate Governance
Corporate Information
Cost Maintenance
Cost Pools
Counterparts
Covenant Against Liens
Covenant Quiet Enjoyment
Cpr
Credit Agreement
Criteria Board Membership
Critical Accounting Policies Estimates
Current Products
Curtis Cluff
David Goldstein
Debt Ability Incur Substantial Additional Principal Interest Payment
Debt Issuance Costs
Debt Issuance Costs Extinguishment
Deductibility Executive Compensation
Defaults
Definitions
Definitions Key Terms Relating Additional Rent
Delay Restoration
Department Stores Channel
Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Principal Officers Election Appointment Certain
Deposit Account
Derivative Financial Instruments
Description Business Basis Presentation
Determination Option Rent
Determinations Changes Exceptions Plan
Developers Acknowledgment
Development Fee
Direct Advertising Sales Support
Director Compensation
Director Nominations
Directors Executive Officers Corporate Governance
Disclosing Party
Disclosure Controls Procedures
Discretionary Annual Bonus
Dispute
Distribution
Distributor8221
Dividends
Document
Domestic
Drug Stores
Drug Stores Variety Channel
Earnings Outlook Raised Net Sales Guidance Reiterated
Earnings Per Common Share Eps
Edward Grant
Effect Transfer
Effective Date
Efforts Relet
Elastiderm Products
Elastiderm- Anti-aging
Elastiderm-anti-aging
Elements Compensation
Employees
Employment Agreement
Employment Agreements
Employment Agreements Potential Payments Termination Change Control
Entire Agreement
Entry Landlord
Entry Material Definitive Agreement
Environmental Condition
Equipment
Estimates
Estoppel Certificates
Evaluation Disclosure Controls Procedures
Exchange Rate Manner Place Payment
Executive Compensation
Executive Officers
Exercise Option
Exhibits
Expanded Applications Existing Products
Expansion Rent
Expansion Space
Expect Price Common Stock Fluctuate Substantially
Extended Term
Face Intense Competition Some Cases Companies Significantly Greater
Fail Generate Sufficient Cash Flow Operations Unable Continue
Failure Obtain Regulatory Approvals Foreign Jurisdictions Prevent Marketing
Failure Successfully In-license Acquire Additional Products Technologies Impair
Fair Values Financial Instruments
Favor
Fda Enforcement Discretion Marketed Unapproved Drug Products
Fda Issued Proposed Rule Cites Evidence Active Ingredient
Fda Regulation Cosmetics
Fda Regulation Drug Manufacturing
Fda Regulation Drug Products
Fda Regulation New Drug Products
Federal Regulation Advertising Promotion
Field8221
Financial Guidance 2008
Financial Performance
Financial Performance Base Bonus Target Payment Scale
Financial Performance Incentive Plan
Financial Statements Exhibits
Financial Statements Supplementary Data
Fluctuations Demand Products Create Inventory Maintenance Uncertainties Adversely
Force Majeure Event
Forecasts
Foreign Currency Fluctuations
Foreign Currency Translation
Form 10-k
Form 10-q
Form 8-k
Form Payment After Default
Form Policies
Former Name Address Changed Since Last Report
Forward Looking Statements
Forward-looking Statements
Full 2007 Financial Results
Full Financial Results
Full Floors
Future
Future Growth
Future Products
Future Rohto Licensed Products
Future Sales Common Stock Perception Public Markets Occur
Gain Legal Settlements
General
General Intangibles
General Release Not Extend Claims
General Terms
Generally
Goodwill Other Intangible Assets
Goodwill Other Intangibles
Governing Law
Governing Law Severability
Government Regulation
Governmental Authority
Grants Plan-based Awards
Gross Margin Percentage
Growth Suffer Economic Downturn Major Markets Inhibits People
Guaranteed Obligations
Guarantors
Guaranty
Guidance
Headings
Held 2007
Held 2008
Holders
Holding Over
Icc Rules
Impairment Long-lived Assets
Impairment Significant Intangible Assets Reduce Profitability
Improvements New Products
Income Tax Withholding
Income Taxes
Incur Costs Result Being Public
Incur Increased Costs Result Being Public
Indemnification Waiver
Indemnifications
Indemnified Person
Indemnitee
Index
Inflation
Initial Lease Term
Initial Period8221
Initial Public Offering
Initial Term
Instrument
Insurance Proceeds
Intangible Assets
Intellectual Property
Intellectual Property Collateral
Interest Dermatology Clinic Customers
Interest Income Expense
Interest Rate Cap
Interest Rate Cap Agreement
Interest Rate Risk
Interests Controlling Stockholder Conflict Other Stockholders
International
International Distribution
Interpretation
Interruption
Inventories
Inventory
Investment Property
Involved Intellectual Property Claims Litigation Proceedings Divert Resources
Istributor Expenses
John Bartholdson
John Duerden
Joint Product Channel Development Opportunities
Joint Several Obligation Etc
Jose Ramirez
Jose Ramirez Chem
Jr8221
Judith Hattendorf
Jury Trial Waiver
Kilroy Airport Center Long Beach Phase
Landlord Restoration Work Regard Improvements
Landlords Acknowledgment
Landlords Consent
Landlords Consent Alterations
Landlords Delivery Premises
Landlords Option Repair
Landlords Option Subject Space
Landlords Property
Late Charges
Lease Agreement Letter
Lease Agreements
Lease Commitments
Leases
Leaves Absence Termination Employment
Legal Description
Legal Proceedings
Lenders
Letter Credit Agreements
Liaison
License Know-how
License Omp Developed Products Jointly
License Term8221
Licensed Products
Licensed Technology8221
Licensing
Limitation Applicable Insolvency Laws
Limitations Traditional Products Procedures
Limited Right Entry 8212
Line Credit Notes Payable Capital Lease Obligations
Liquidity Capital Resources
Litigation
Location Monument Sign
Long Beach Calif 2007
Long Beach Calif 2008
Long Beach Calif 8212 2009
Long Term Obligations
Long-term Debt
Long-term Incentive Program
Lose Key Personnel Unable Attract Retain Other Qualified
Management Services Agreement
Managements Report Internal Control Over Financial Reporting
Manner Construction
Manufacturers Suppliers License Certain Technologies Patents Parties Licenses
Manufacturing
Market Information
Market Opportunity
Market Registrants Common Equity Related Stockholder Matters Issuer
Marketed Products Development Rendered Obsolete Technological Medical Advances
Marketing Reports Brand Protection
Master Ground Lease
Material Weakness Related Application Implementation Generally Accepted Accounting
Material Weakness Related Completeness Accuracy Accounts Payable Accrued
Material Weakness Related Valuation Intangible Assets
Metered Utilities
Method Allocation
Minimum Performance Level
Miscellaneous
Multi-tenant Floors
Mutual Release
Net Sales
New Accounting Pronouncements
New Accounting Standards
New Guarantor
New Regulations Prohibit Physicians Dispensing Products Directly
Nominating Corporate Governance Committee
Nominees Continuing Directors
Non-disclosure Third-party Information
Non-employee Directors Shall Reimbursed Travel Expenses Incurred Attending
Non-gaap Financial Measures
Non-gaap Income Tax Expense Benefit
Non-gaap Net Income Per Basic Dilute Share
Non-gaap Net Income Per Basic Diluted Share
Non-solicitation Non-interference
Non-transfers
Nonsolicitation Non-interference
Nonwaiver
Not Able Successfully Expand Current Product Lines Develop
Not Applicable
Not Intend Pay Cash Dividends Common Stock Foreseeable
Notice
Notice 8212
Notice Breach
Notices
Now Therefore
Nu-derm
Obagi
Obagi Blue Peel
Obagi Clenziderm
Obagi Condition Enhance Basal Cell Carcinoma
Obagi Condition Enhance Botox
Obagi Condition Enhance Laser
Obagi Elastiderm
Obagi Medical Products Approach
Obagi Medical Products Inc
Obagi Medical Products Inc Certification Chief Executive Officer
Obagi Medical Products Inc Certification Chief Financial Officer
Obagi Medical Products Omp Inc 310 Golden Shore
Obagi Medical Products Reports Record 2007 Net Sales
Obagi Nu-derm Condition Enhance Basal Cell Carcinoma
Obagi Nu-derm Condition Enhance Botox
Obagi Nu-derm Condition Enhance Laser
Obagi Nu-derm System
Obagi Professional-c
Obagi Responsibilities
Obagi Systems Related Products
Obagi-c System
Objectionable Name
Obligations Investors Rights Agreement
Obligations Survive Termination Employment
Occurrence Default
Office Lease
Omp
Omp Developed Products
Omp Inc
Omp Inc 310 Golden Shore Floor Long Beach
Omp Indemnitees
Operating Expenses Inclusions
Operating Leases
Option Exercises Stock Vested
Option Rent
Option Right
Options
Otc Monograph System
Other Compensation
Other Government Regulation
Other Matters
Other Terms
Other Transactions
Outline Premises
Outlook
Over-achievement Performance Objectives
Overstandard Tenant
Overview
Overview Compensation Program
Overview Recent Developments
Parking Rules Regulations
Part
Patent Licenses
Patent Rights
Patents
Payment Improvements
Payment Reports
Payment Terms
Performance Awards Dividend Equivalents Other Stock Grants Stock-based
Performance Graph
Performance Objectives Fund Plan Pool
Performance Thresholds
Permitted
Perquisites Other Personal Benefits
Plan
Plan Incentives Earned Paid
Plan Participants
Plan Period
Plan Pool
Plan Pool Funding
Plan Pool Funding Table
Please Complete Date Sign Proxy Return Promptly Enclosed
Policies Procedures Reviewing Approving Ratifying Related Party Transactions
Position Responsibilities
Potential Business Combinations Require Significant Management Attention Prove
Potential Payments Termination Change Control
Premises
Preston Romm
Price Changes Notification
Principal Accountant Fees Services
Principal Accounting Fees Services
Principles Consolidation
Prior Agreement
Prior Licensed Rohto Products
Procedure Acceptance Expansion Space
Procedure Offer Expansion Space
Proceeds
Proceeds Sale Registered Securities
Process Identifying Evaluating Nominees
Product
Product Know-how
Product Liability Lawsuits Divert Resources Result Substantial Liabilities
Product Patents
Product Supply Agreement
Product8221
Products Cause Undesirable Side Effects Limit Require Removal
Prohibited Signage Other
Prohibited Uses
Properties
Property Equipment
Proposal 1-election Directors
Proposal 2-ratification Independent Registered Public Accounting Firm
Proration Operating Expenses
Provisions Charter Documents Delaware Law Discourage Takeover Consider
Proxy Solicited Board Directors Annual Meeting Stockholders Held
Purchase Order
Quantitative Qualitative Disclosures Market Risk
Quarterly Financial Data
Quarterly Operating Results Variable Cause Stock Price Decline
Raises Outlook 2007 Earnings
Receiving Party
Recent Accounting Pronouncements
Recent Sales Unregistered Securities
Recitals
Reclassifications
Recognition Landlords Notice Nonresponsibility
Registered Public Offering Costs
Regulation Disclosure
Regulatory Approval
Related-party Transactions
Release Reinstatement
Remedial Action
Remediation
Remediation Material Weaknesses
Remedies Default
Remedies Right Offset
Removal Tenant Property
Repair Damage Premises Landlord
Repairs
Report Audit Committee
Report Compensation Committee
Reports 2007 Financial Results
Representations Warranties Covenants
Research Development
Restricted Assets
Restricted Stock
Restricted Stock Units
Results
Results 2007
Results 2008
Results Operation Financial Condition
Results Operations
Revenue Recognition
Reverse Stock Split
Revised 2008 Financial Guidance
Revisions Financial Guidance
Right Cure
Risk Factors
Risks Related Business
Risks Related Regulatory Matters
Rohto Indemnitees
Rohto Licensed Products
Rohto Pharmaceutical Ltd
Rohto8221
Role Executive Officers Compensation Decisions
Ronald Badie
Royalty
Royalty Licensee Agreements
Royalty Rates
Royalty Term
Sales Growth
Sales Marketing
Sales Returns Allowances
Sales Revenues Other Customers
Sales Revenues8221
Schedule
Schedule 14a
Scs Services Responsibilities
Seasonality
Sec
Secondary Public Offering
Securities Account
Securities Authorized Issuance Equity Compensation Plans
Security Deposit
Security Ownership Certain Beneficial Owners Management Related Stockholder
Selling General Administrative
Separation Agreement General Release
Separation Release Agreement
Separation Release Non-compete Agreement
Services Agreement
Settlement Consent Agreement Mutual Release
Severability
Severance Agreements
Short Form Intellectual Property Security Agreements8221
Signature
Signatures
Site Plan
Skin Care Market
Skin Damage Disorders
Software
Specifications
Specifications Permits
Specifications8221
Statement Actual Direct Expenses Payment Tenant
Statement Estimated Direct Expenses
Stephen Garcia
Steven Carlson
Stock Appreciation Rights
Stock Options Restricted Units
Stock Repurchase Plan
Stock-based Compensation
Stockholder Nominees
Stockholder Proposals 2008 Annual Meeting
Stockholder Proposals 2010 Annual Meeting
Stonington Capital Appreciation 1994 Fund
Strengthened Balance Sheet
Subject Requirements 404 Sarbanes-oxley Act Unable Comply Timely
Subject Risks Associated Doing Business Internationally
Subleases Tenant
Submission Matters Vote Security Holders
Subordination
Subordination 8212
Subrogation
Subsequent Events
Substitution Premises
Subtenants Acknowledgment
Successful Initial Public Offering Balance Sheet Data
Sued Estate Austin Mcnamara Former Chairman Chief Executive
Summary Compensation Table
Surety Bond
Surrender Premises
Tax Accounting Implications
Taxes
Tenant Parking
Tenants Audit Rights
Tenants Obligations
Tenants Security System
Term
Term8221
Termination License
Termination Obligations
Termination Right Tenants Signage
Territory
Third-party Claims Expenses
Third-party Manufacturers Not Operate Accordance Current Good Manufacturing
Trademark Collateral
Trademark Licenses
Trademarks
Transfer Premium
Transferee Not Intend Occupy Entire Subject Space Conduct
Transfers
Transition Report Pursuant Securities Exchange Act 1934
Treasury Stock
Tretinoin
Triax
Triax Pharmaceuticals
Ucc
Unable Protect Proprietary Rights Not Able Compete Effectively
Unconditional Character Guaranty
Unit8221
Unregistered Sales Equity Securities Proceeds
Valid Claim8221
Variety Stores
Vehicles
Ventiv Commercial Services Llc
Volume Target
Vote Important
Waiver
Waiver Statutory Provisions
Waiver Subrogation
Washington 20549
Whereas
Witness Whereof
Zein Obagi
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour